click below
click below
Normal Size Small Size show me how
Pharm Tech Final 3
Question | Answer |
---|---|
The second set of numbers in the NDC indicates | The drug name, strength and dosage form |
Exempt narcotics are in this DEA schedule | Schedule V |
The longest phase of clinical drug testing | Phase 3 |
A major piece of federal legislation affecting patients’ privacy rights. | HIPAA |
Manufacturers’ containers for prescription drugs must have this on the label | “Rx only” |
The non-profit organization that sets standards for the manufacture and distribution of drugs and related products in the U.S. | USP |
The main purpose of phase 2 clinical drug testing | efficacy |
The combat methamphetamine epidemic act sets ---- and ---- restrictions on the amount of ephedrine or pseudoephedrine that can be sold over the counter to an individual | daily, monthly |
--- refers to failure to do something that should or must be done. | negligence |
An independent non-profit organization that establishes standards and monitors compliance for hospitals and other health care programs. | JCAHO |
Which of the following DEA numbers is consistent with the DEA formula for Dr. John Doe? | BD8822567 |
Exempt narcotics can be sold by a pharmacists to a person at least --- years of age | 18 |
Prescriptions cannot be transferred from one pharmacy to the other | false |
Independent non-profit organization that sets quality standards for prescription drugs, OTC drugs, and dietary supplements | USP |
Independent non-profit organization which established standards and monitors compliance in hospitals, health care networks, HMOs, and nursing homes | JCAHO |
FDA requires drug manufacturers to file this before initiating a clinical trial in humans | Investigational New Drug Application |
By prescription only | Legend Drug |
common name given to a drug regardless of brand name | Generic |
Prescriptions that can be refilled up to 5 times in 6 months. | C-III to C-IV |
FDA requires pharmaceutical manufacturer to file this with each new drug before marketing. | New Drug Application |
Pharmacist in Charge | PIC |
Name under which the manufacture markets a drug | Brand |
A unique and permanent product code assigned to each drug | National Drug Code |
Prescription information which comes with a document on the drug product, and is also contained in a book called PDR. | Package Insert |
Prescriptions can never be refilled. | C-II |
The third set of numbers in the NDC indicates | the package size |
The largest area of the PTCE | assisting the pharmacist in serving patients |
To make an accounting of items on hand | inventory |
Drugs in this DEA schedule have no accepted medical use | Schedule I |
The ASHP has developed a national model curriculum. | True |
Under HIPPA, PHI stands for | protected health information |
Individuals in health care who are given a basic level of training designed to help them perform specific task s | technicians |
The Controlled Substances Act was established by | the U.S. Congress |
The second set of numbers in the NDC indicates | the drug name, strength, and dosage form |
The first set of numbers in the NDC indicates | the manufacturer |
This law allowed for quicker introduction of lower-cost generic drugs | Hatch Waxman Act |
Demonstration of competency during a pharmacy technician’s training is generally through | written tests and practical demonstrations |
Specific responsibilities and tasks for pharmacy technicians are determined by | employers |
This law defines what drugs require a prescription | Durham-Humphrey Amendment |
ASHP is the leading association for | pharmacists practicing in hospitals and other health care systems |
Being capable and qualified | competent |
Patient information is considered public information | False |
Licensed pharmacists are legally responsible for the work of pharmacy technicians and provide direct supervision of pharmacy technicians | True |
Technicians may sometimes provide counseling services to patients | False |
To renew their certification, CPhTs must complete at least | 20 contact hours of pharmacy-related continuing education every two years |
This law provides regulations for the transfer of patient health information | Health Insurance Portability and Accountability Act |
The organization that accredits pharmacy residency and pharmacy technician training programs | ASHP |
Anabolic steroids are in this DEA schedule | Schedule III |
The form required to order Schedule I or Schedule II controlled substances | DEA Form 222 |
Drugs in this DEA schedule have no accepted medical use | Schedule I |
The first set of numbers in the NDC indicates | the manufacturer |
This law defines what drugs require a prescription | Durham-Humphrey Amendment |
It is the responsibility of ------- to provide proof that a drug is safe and effective | the manufacturer |
Which is not a medication that is controlled under the Combat Methamphetamine Act? | Plan B |
This law established the DEA as a division of the Justice Department, and classifies five levels of drugs that have potential for abuse. | Controlled Substances Act |